While most clinicians associate the presence of BCR-ABL fusion gene with chronic myeloid leukemia (CML), about 10% of healthy control patients express at least some measurable copies in their peripheral blood [97]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.